Page 166 – Clinical Laboratory int.

Astellas, We are Pioneer Group launch Future Innovator Prize for pioneering biotechs

, 2 November 2021/in E-News /by panglobal

Astellas Venture Management, a wholly-owned venture capital subsidiary of Astellas Pharma, and We are Pioneer Group (WAPG), the UK’s largest ecosystem provider for science and innovation businesses, have set up a new collaborative sponsorship and first-of-its-kind initiative to support early stage science ventures.

Clinical toxicology screening: expanding the capability of highresolution mass spectrometry

, 2 November 2021/in Featured Articles /by 3wmedia

High-resolution mass spectrometry (MS) is a powerful analytical tool for clinical and forensic toxicology. It is capable of screening and confirming the presence of drugs and toxic compounds in various biological matrices. Using high-resolution MS/MS libraries helps to increase reporting confidence, verifies compound identification and reduces reporting of false-positive results.

Diagnosis of acute hepatic porphyria

, 2 November 2021/in Featured Articles /by panglobal

The acute porphyrias are a group of rare genetic metabolic disorders of the heme biosynthesis pathway, that result in the toxic accumulation of porphyrin precursors, notably porphobilinogen and delta-aminolevulinic acid. This article provides an overview of the biochemistry and the diagnosis of acute hepatic porphyria, which is crucial to managing this condition appropriately, preventing and […]

Insight into tumour marker development

, 2 November 2021/in Featured Articles /by panglobal

The growth of molecular genetic technologies has enabled advances in personalized medicine, particularly in the field of cancer diagnosis, prognosis and therapeutic decision-making. CLI caught up with Dr Jennifer Keynton (Diagnostics R&D Manager at Horizon Discovery) to find out more about the development of tumour markers and the role of reference standards in cancer diagnostics […]

Potential breakthrough in early diagnosis of HPV16 cancers

, 2 November 2021/in Featured Articles /by 3wmedia

The link between human papillomaviruses (HPVs) as the causal agents of anogenital warts and most incidences of cervical cancer has been longestablished, and it is in this background that the vaccine against HPV has been developed. However, more recently, HPV has also been found to be responsible for the increasing incidence and death from head, […]